From last Friday: New buy, old friend - Viking Therapeutics (VKTX- $31.11) More on Monday. By Doug Kass Mar 6, 2026 9:45 AM EST --- The quick case for Viking Therapeutics VKTX: * Top-tier efficacy and safety into Phase 3 trials * The company has the same type of molecule as the superior ...
Read in context ›Eli Lilly & Co Stock (LLY)
Track Eli Lilly & Co stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
LLY
Eli Lilly & Co
healthcare
$1,127.71
▲ +362.80 (+50.38%) past year
Market Cap
$1.00T
P/E Ratio
27.8x
1Y Return
+50.38%
EPS (TTM)
$27.78
Read the latest TheStreet Pro articles mentioning Eli Lilly & Co, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
111 articlesDaily Diary Mentions
20 mentionsThe Case for Viking Therapeutics Berkshire Buys a Stake in United Health * I am making some sales in the premarket at $307 After the market closed on Thursday, Berkshire Hathaway BRK.A BRK.B revealed that it had purchased five million shares of United Healthcare UNH last quarter. (See: Warren…
Read in context ›Riddle Me This, Indices! Remember the days that I showed the underperformance/divergence of RSP (equal-weighted S&P index) and IWM vis-à-vis the S&P and Nasdaq indices? I thought that was a troublesome signpost, but I was wrong. Well, wha…
Read in context ›Remember Two Days Ago? Nasdaq is now lower on the day and value is in its second or third of a strong rally. Two days ago, I wrote this: Buying Value, Shorting Momentum I initiated three new investment longs (deep value) late last week — UNH ,…
Read in context ›No More LLY Out of LLY at $651.
Read in context ›